Abdominal Aortic Aneurysm
Medtronic Starts First Human Study of Endurant(TM) Stent Graft System for Treatment of Abdominal Aortic Aneurysm
Published in Cardiovascular Business Week, January 1st, 2008
The study supports Medtronic's goal of providing physicians with a greater variety of solutions for treating patients with AAA - a dangerous bulge or weakness in the body's main artery that can rupture with fatal consequences if left untreated. The company's AAA stent graft portfolio currently includes the AneuRx AAAdvantage(R) platform in the United States and the Talent(TM) AAA platform outside the United States. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- American Heart Association
News from the American Heart Association - Association for Professionals in Infection Control and Epidemiology
APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS - Biotechnology Business
Abiomed Receives FDA Approval for the Combination iPulse(TM) Circulatory Support System - Biotechnology Business
Alexza Elects Dr. Hal V. Barron to Its Board of Directors - Biotechnology Business
SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors - Blood Pressure
Susan Samueli Center Research Shows Acupuncture Can Lower Blood Pressure as Much as 40 Percent - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
